Research programme: viral infections - Altesa BioSciences/Drug Innovations Ventures at Emory/Emory University
Latest Information Update: 09 Mar 2022
At a glance
- Originator Emory University
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Viral infections